5/4/2022 3:57:33 PM
Biogen's debated Alzheimer's drug given to first
First patient receives Biogen Alzheimer's drug
Biogen's debated Alzheimer's drug given to first patient. A Rhode Island man became the first patient worldwide to receive Biogen’s hotly debated Alzheimer’s drug outside of a clinical trial on Wednesday, a hospital spokesperson confirmed to Fox News. Marc Archambault, 70 of Wakefield, received the infusion shortly before noon at Butler Hospital in Providence, according to spokesperson Raina Smith of Care New England. The patient met the criteria for people diagnosed with mild cognitive impairment or early Alzheimer’s disease, Smith said. Check out the link to read more about this.
4/30/2022 3:19:58 PM
4/30/2022 6:47:25 AM
2/8/2022 10:59:52 PM
1/12/2022 2:47:16 AM
12/31/2021 12:05:30 AM
12/29/2021 9:21:16 PM
10/31/2021 8:03:27 PM
10/18/2021 7:59:00 PM
10/8/2021 6:40:11 PM
10/8/2021 5:05:01 PM
10/8/2021 4:07:27 PM
10/8/2021 1:00:57 PM
10/5/2021 5:20:13 PM
10/5/2021 4:44:04 PM
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
